Search clinical trials for: FGFR rearrangement
Total 334 results
-
Tyra Biosciences, IncRecruitingSolid Tumor | Intrahepatic Cholangiocarcinoma | Metastatic Cholangiocarcinoma | Locally Advanced CholangiocarcinomaUnited States
-
Tianjin Medical University Second HospitalRecruitingSolid Tumor | FGF Receptor Gene Mutation | FGF Amplification | FGF Receptor Gene Family Rearrangement | FGF Receptor Gene TranslocationChina
-
Taiho Oncology, Inc.RecruitingAdvanced Cholangiocarcinoma | FGFR2 Fusions | Gene RearrangementUnited States, Korea, Republic of, Spain, Japan, Portugal, Italy, China, Argentina, Brazil, Poland, Australia
-
Institut für Klinische Krebsforschung IKF GmbH...Incyte Biosciences International SàrlRecruitingIntrahepatic Cholangiocarcinoma | FGFR2 Gene Mutation | FGFR2 Gene Translocation | FGFR2 Gene RearrangementGermany
-
Tyra Biosciences, IncRecruitingSolid Tumor | Bladder Cancer | Advanced Solid Tumor | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | FGFR3 Gene Mutation | Urinary Tract Cancer | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Non-muscle-invasive Bladder Cancer | FGFR3 Gene Alteration | Urinary... and other conditionsAustralia, United States, France, Spain
-
Institut für Klinische Krebsforschung IKF GmbH...RecruitingIntrahepatic CholangiocarcinomaGermany
-
Centre Leon BerardRecruitingCancer | Cancer Metastatic | ALK Fusion Protein Expression | FGFR2 Gene Translocation | FGFR3 Gene Translocation | NTRK Family Gene Mutation | Gene Fusion | ROS1 Gene Translocation | NTRK Gene Fusion Overexpression | ATIC-ALK Fusion Protein Expression | BCR-FGFR1 Fusion Protein Expression | COL1A1-PDGFB Fusion... and other conditionsFrance, Denmark, Netherlands, Austria, Germany, Italy, United Kingdom, Czechia, Poland, Slovenia, Spain
-
Incyte CorporationRecruitingMetastatic Cholangiocarcinoma | Unresectable CholangiocarcinomaUnited States, Canada, Belgium, France, Germany, Italy, China, Spain, Japan, United Kingdom, Netherlands, Switzerland, Austria, Denmark, Finland, Ireland, Israel, Norway, Sweden
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Incyte CorporationActive, not recruitingMPN (Myeloproliferative Neoplasms)United States, France, United Kingdom, Spain, Canada, Japan, Germany, Switzerland, Belgium, Austria, Italy
-
Taiho Oncology, Inc.Active, not recruitingAdvanced or Metastatic Solid Tumor | Advanced or Metastatic Gastric or Gastroesophageal Cancer | Myeloid or Lymphoid Neoplasms (MLN)United States, Spain, Turkey, Hong Kong, Korea, Republic of, Belgium, Japan, Netherlands, France, Germany, Italy, Sweden, United Kingdom, Portugal, Singapore
-
Relay Therapeutics, Inc.Active, not recruitingCholangiocarcinoma | Intrahepatic Cholangiocarcinoma | FGFR2 Gene Mutation | FGFR2 Amplification | FGFR2 Gene Fusion/Rearrangement | FGFR2 Gene Translocation | FGFR2 Gene Activation | Other Solid Tumors, AdultUnited States, France, Italy, United Kingdom, Korea, Republic of, Spain, Taiwan, Sweden, Germany, Netherlands, Singapore, Australia, Hong Kong
-
Taiho Oncology, Inc.Approved for marketingAdvanced CholangiocarcinomaUnited States
-
Incyte CorporationActive, not recruitingGlioblastoma | Adult-type Diffuse GliomasUnited States, Spain, Italy, United Kingdom, Germany, Japan, France, Netherlands, Denmark
-
Taiho Oncology, Inc.Active, not recruitingAdvanced Cholangiocarcinoma | FGFR2 Gene RearrangementsUnited States, Spain, United Kingdom, Australia, Taiwan, Italy, France, Korea, Republic of, Belgium, Japan, Thailand, Germany, Brazil, Peru, Portugal, Argentina, Hong Kong, Mexico, Netherlands, Poland
-
Basilea PharmaceuticaCompletedIntrahepatic Cholangiocarcinoma | Combined Hepatocellular and CholangiocarcinomaCanada, United States, Spain, Belgium, Italy, Korea, Republic of, Germany, Switzerland, France, United Kingdom, Ireland
-
Incyte CorporationCompletedNon-Small Cell Lung Cancer (NSCLC)Spain, United States, Italy, Germany, France
-
Helsinn Healthcare SALabcorp Drug Development IncWithdrawnAdvanced Solid Tumor | CNS Tumor | Recurrent WHO Grade II GliomaUnited States, Canada, Germany
-
Incyte CorporationTerminatedMetastatic Urothelial Carcinoma | Unresectable Urothelial CarcinomaSpain, France, United States, Italy, Japan, Ireland, Slovakia, Austria, Belgium, Canada, Finland, Germany, Poland, Portugal, Romania, United Kingdom
-
Massachusetts General HospitalNot yet recruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia in Remission | NPM1 Mutation | KMT2A RearrangementUnited States
-
M.D. Anderson Cancer CenterIncyte CorporationNot yet recruitingAdvanced Cholangiocarcinoma | FGFR2 FusionUnited States
-
QED Therapeutics, Inc.RecruitingHypochondroplasiaUnited States, Australia, Norway, Portugal, Singapore, Spain, Canada, France, Germany, Sweden, United Kingdom
-
Chulalongkorn UniversityNot yet recruitingUltrasound Finding: Ovulation Inhibition, Ovarian Activities | Cervical Mucus | Serum Hormonal Profile
-
3H (Suzhou) Pharmaceuticals Co., Ltd.Not yet recruitingSolid Tumors With FGFR2 Alterations, AdultChina
-
MedSIRMedical University of ViennaNot yet recruitingNSCLC | Brain Metastases | ROS1 Gene Rearrangement
-
Hacettepe UniversityNot yet recruitingRespiratory Function Test | Balanced; Rearrangement
-
Australasian Leukaemia and Lymphoma GroupNot yet recruitingHigh-grade B-cell Lymphoma | DLBCL - Diffuse Large B Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | DLBCL, Nos Genetic Subtypes | High Grade B-Cell Lymphoma, Not Otherwise Specified | Follicular Large Cell Lymphoma, Relapsed | Follicular Large Cell Lymphoma
-
3H (Suzhou) Pharmaceuticals Co., Ltd.Not yet recruitingSolid Tumors With FGFR2 Alterations, AdultUnited States
-
BrodenBio Co., Ltd.Recruiting
-
Atara BiotherapeuticsRecruitingHigh-grade B-cell Lymphoma | MCL | Diffuse Large B-cell Lymphoma (DLBCL) | Relapsed/Refractory B-cell Non-Hodgkin Lymphoma | DLBCL/High-grade B-cell Lymphoma With MYC and BCL2 Rearrangements | Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma | LBCL With IRF4 Rearrangement | High-grade B-cell... and other conditionsUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityNot yet recruitingDiffuse Large B-Cell Lymphoma | High Grade B-Cell LymphomaUnited States
-
Uma BorateRecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia With FLT3/ITD Mutation | Acute Myeloid Leukemia With KMT2A Rearrangement | Acute Myeloid Leukemia With NPM1 MutationUnited States
-
LianBio LLCRecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaChina
-
National Cancer Center, JapanOno Pharmaceutical Co. LtdRecruitingPancreatic Cancer | Low-grade GliomaJapan
-
Guangzhou JOYO Pharma Co., LtdRecruitingLung Neoplasms | Brain Neoplasms | Protein Kinase Inhibitors | Other Protocol Specified CriteriaChina
-
Bernie EiglLady Davis Institute; Vancouver Prostate Centre; Bladder Cancer CanadaRecruitingMetastatic Urothelial Carcinoma | Metastatic Bladder CancerCanada
-
Hunan Province Tumor HospitalRecruitingAdvanced Solid Tumors or LymphomasChina
-
TransThera Sciences (Nanjing), Inc.RecruitingCholangiocarcinoma MetastaticChina
-
RenJi HospitalShanghai Zhongshan Hospital; Ruijin HospitalRecruitingClear Cell Renal Cell Carcinoma、Resistance to ImmunotherapyChina
-
Professor Ernest Hung-Yu NgNot yet recruitingInfertility | Aneuploidy | Genetic Disease | Chromosomal RearrangementChina
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingGenetic Predisposition to Disease | Gene Rearrangement | Genome InstabilityItaly
-
Kura Oncology, Inc.RecruitingNeoplasms by Histologic Type | Acute Myeloid Leukemia | Leukemia | Leukemia, Myeloid | Leukemia, Myeloid, Acute | AML | Acute Leukemia | Hematologic Malignancy | NPM1 Mutation | AML With Mutated NPM1 | KMT2Ar | MLL RearrangementUnited States
-
Sun Yat-sen UniversityNot yet recruitingLocally Advanced Unresectable Gastric CancerChina
-
Joshua PalmerGenentech, Inc.RecruitingNSCLC | Lung Cancer | Brain MetastasesUnited States
-
TransThera Sciences (Nanjing), Inc.RecruitingCholangiocarcinomaKorea, Republic of, Spain, United States, Taiwan, Italy, France, Belgium, Germany, Portugal, United Kingdom, Austria, Poland, Netherlands
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Incyte Corporation; Ipsen; BeiGeneRecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma | Grade 3b Follicular Lymphoma | Transformed Non-Hodgkin Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsUnited States
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia With KMT2A Rearrangement | Acute Myeloid Leukemia With NPM1 MutationUnited States
-
Kidney Cancer Research BureauRecruitingMetastatic Gastric Cancer | FGFR2 Amplification | PD-L1 Gene AmplificationUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruiting
-
Boundless BioRecruitingBreast Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Bladder Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Liposarcoma | Non-Small Cell Squamous Lung Cancer | Non-Small Cell Lung AdenocarcinomaUnited States